new post
StocksRunner logo
mail
search
 
menu
 
BridgeBio Oncology T
$9.99
-1.96%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

BBOT Stock Analysis & IQ Rating | BridgeBio Oncology Therapeutics

 
 

BBOT

 

BridgeBio Oncology Therap

$9.99

 
-$0.20 | -1.96%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$14.87
 
 
MKT CAP
$800.31M
 
52W Low
$8.5
 
 
VOL
$113.73K
 
P/E Ratio
50.05
 
 
AVG VOL
$269.17K
 
RSI
42.01
 
 
TREND
Downtrend
 
 
 

BBOT Stock IQ

 
lock  Login to see BridgeBio Oncology Therap (BBOT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

BBOT Target Price

 
 
 

Strengths

 
 

BBOT Rewards

 Upgraded on attractively valued

BBOT Rewards

 Earnings are forecast to grow

BBOT Rewards

 Outperform the market

 
 

BBOT Price Performance

 
 

$12.04   (-17.03%)

$12.59   (-20.65%)

$11.95   (-16.40%)

$8.94   (+11.74%)

 
 
1year
6month
3month
1month

BBOT Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

BBOT Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

Future

×

Future

BBOT Future Sentiment Earnings are forecast to grow
BBOT Future Sentiment Outperform the market
BBOT Analysts Opinion

BBOT Analysts opinion is negative and it remained unchanged from the past 3 months

BBOT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%
Consensus Rating
100%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
BBOT Street Sentiment

BBOT Street Sentiment is extremely bullish and have positive views on the near-term outlook

BBOT Risk Level

BBOT has Fair risk level

Risk Indicators

Low volume
High volatilty
BBOT Risk Level
Fair
LOW
HIGH

BBOT Performance Sentiment

Sentiments overview associated with events and the stock performance

100%
Positive
8 out of 8
events present
0%
Negative
0 out of 8
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
N/A
Resistance Price
$11.50
Current Price Range
$10.19
N/A
$11.50
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
4
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Jan 10, 2026

 

Initiate

 

Outperform

 

Raymond James

 

Dec 12, 2025

 

Reiterate

 

Outperform

 

Wedbush

 

Nov 26, 2025

 

Reiterate

 

Outperform

 

Wedbush

 

Nov 14, 2025

 

Reiterate

 

Outperform

 

Oppenheimer

 
 
 
BBOT Latest Analysis +
 
 
FAQ About BBOT Stock Insights
 

What is BBOT current stock price?

What are BBOT stock strengths?

What is BBOT Risk Level?

What is BBOT market cap and volume?

What is BBOT current Stock IQ?

Should I buy BBOT stock right now?

Is BBOT a Strong Buy right now?

What does a 'Strong Buy' rating mean for BBOT?

What does a 'Strong Sell' rating mean for BBOT?

What factors influence BBOT's Stock IQ?

 
 
StocksRunner

Explore our BBOT Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored BBOT Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our BBOT Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

BBOT

 

BridgeBio Oncology Therap

 
Set Alerts
 
 

Current Price

 

$9.99

 
-$0.20 | -1.96%
 
 
52W High
$14.87
 
 
MKT CAP
$800.31M
 
52W Low
$8.5
 
 
VOL
$113.73K
 
P/E Ratio
50.05
 
 
AVG VOL
$269.17K
 
RSI
42.01
 
 
TREND
Downtrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

BBOT Price Performance

 
 

$12.04   (-17.03%)

$12.59   (-20.65%)

$11.95   (-16.40%)

$8.94   (+11.74%)

 
 
1year
6month
3month
1month
 

BBOT Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

BBOT Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

Future

×

Future

BBOT Future Sentiment Earnings are forecast to grow
BBOT Future Sentiment Outperform the market
BBOT Analysts Opinion

BBOT Analysts opinion is negative and it remained unchanged from the past 3 months

BBOT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%
Consensus Rating
100%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
BBOT Street Sentiment

BBOT Street Sentiment is extremely bullish and have positive views on the near-term outlook

BBOT Risk Level

BBOT has Fair risk level

Risk Indicators

Low volume
High volatilty
BBOT Risk Level
Fair
LOW
HIGH
BBOT Performance Sentiment
Sentiments overview associated with events and the stock performance.
100%
Positive
8 out of 8
events present
0%
Negative
0 out of 8
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
N/A
Resistance Price
$11.50
Current Price Range
$10.19
N/A
$11.50
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
4
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Jan 10, 2026
Initiate
Outperform
Raymond James
Dec 12, 2025
Reiterate
Outperform
Wedbush
Nov 26, 2025
Reiterate
Outperform
Wedbush
Nov 14, 2025
Reiterate
Outperform
Oppenheimer
 
 
 
 

BBOT Stock IQ

 
 
 
lock  Login to unlock BridgeBio Oncology Therap (BBOT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

BBOT Rewards

 Upgraded on attractively valued

BBOT Rewards

 Earnings are forecast to grow

BBOT Rewards

 Outperform the market

 
 
 

BBOT Latest Analysis

 
 
 

BridgeBio Pharma Inc. (BBIO) Presents at Barclays 28th Annual Global Healthcare Conference Transcript.

 

Today

$9.99 | -1.96%
 
Activity

JPMorgan adds BridgeBio to focus list lifts target to $94.

 

Today

$9.99 | -1.96%
 
Potential

William Blair Initiates Coverage of BridgeBio Pharma (BBIO) with Outperform Recommendation. Fintel reports that on March 10 2026 William Blair initiated coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a Outperform recommendation. Analyst Price Forecast Suggests 33.36% Upside

 

Today

$9.99 | -1.96%
 
Potential
Rating

BridgeBio (BBIO) Soars 13% on Double-Digit Price Target Upgrade. BridgeBio Pharma Inc. (NASDAQ:BBIO) is one of the 10 Stocks Investors Are Watching. BridgeBio saw its share prices jump by 13.22 percent on Tuesday to close at $74.32 apiece as investors took path from an investment firms double-digit price target upgrade for its stock. In a market report JPMorgan raised its price target for BridgeBio [….]

 

Today

$9.99 | -1.96%
 
Momentum

BridgeBios Rare-Disease Pipeline Sparks Growth Buzz. BridgeBio Pharma Inc. (NASDAQ:BBIO) is drawing renewed investor attention as the biotech company advances a slate of rare-disease therapies toward potential regulatory filings and commercial launches.William Blair initiated coverage on the commercial-stage biotech highlighting the company’.s expanding pipeline of treatments targeting rare genetic conditions.BridgeBio’.s Unique PositionAnalyst John Boyle wrote “.BridgeBio is in a

 

Tue Mar 10, 2026

$10.19 | -1.16%
 
Potential

Truist Raises Its Price Target on BridgeBio Pharma Inc. (BBIO) to $95 and Maintains a Buy Rating.

 

Fri Mar 6, 2026

$10.42 | +5.36%
 
Potential
 
 
 
 
 
StocksRunner

Discover BBOT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of BBOT. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our BBOT Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BBOT Stock trends

BBOT Stock performance

BBOT Stock analysis

BBOT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

BBOT Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BBOT

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BBOT

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.